ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

HCM.GB HUTCHMED China Limited

310.00
0.00 (0.00%)
14:56:11 - リアルタイムデータ
名称 銘柄コード 市場 種別
HUTCHMED China Limited HCM.GB Aquis Stock Exchange Ordinary Share
  前日比 前日比 % 現在値 時刻
0.00 0.00% 310.00 14:56:11
始値 安値 高値 終値 前日終値
310.00 310.00 310.00 310.00
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/1/1116:00RNSNONHutchmed (China) Limited Sovleplenib NDA Granted Priority..
2023/12/2917:30UKREGHutchmed (China) Limited Total Voting Rights
2023/12/2917:30UKREGHutchmed (China) Limited Blocklisting Six Monthly Return
2023/12/2119:00UKREGHutchmed (China) Limited Overseas Regulatory Announcement
2023/12/1316:00RNSNONHutchmed (China) Limited Inclusion in National Reimbursement..
2023/12/0719:04UKREGHutchmed (China) Limited Overseas Regulatory Announcement
2023/12/0116:00RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
2023/11/3017:30UKREGHutchmed (China) Limited Total Voting Rights
2023/11/0916:00UKREGHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM)..
2023/10/2417:30UKREGHutchmed (China) Limited Vesting of awards under the LTIP
2023/10/1617:30RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
2023/9/2917:30RNSNONHutchmed (China) Limited NDA Submission for Fruquintinib in..
2023/9/2917:30UKREGHutchmed (China) Limited Total Voting Rights
2023/9/1417:30UKREGHutchmed (China) Limited Director's Share Dealing
2023/9/1217:30RNSNONHutchmed (China) Limited Phase IIIb Savolitinib Results at..
2023/9/1215:00RNSNONHutchmed (China) Limited Patient Enrollment Completed for..
2023/8/3117:30UKREGHutchmed (China) Limited Total Voting Rights
2023/8/2915:00RNSNONHutchmed (China) Limited BTD in China for Savolitinib for..
2023/8/2115:00UKREGHutchmed (China) Limited Sovleplenib Phase 3 Study Meets..
2023/8/0717:30UKREGHutchmed (China) Limited Exercise of Share Options by a..
2023/7/3120:00UKREGHutchmed (China) Limited Interim Results and Business..
2023/7/2015:00RNSNONHutchmed (China) Limited Breakthrough Therapy Designation..
2023/7/1317:30UKREGHutchmed (China) Limited Changes to Board and Technical..
2023/7/1015:00RNSNONHutchmed (China) Limited Phase 1 Study of HMPL-415 Initiated
2023/6/2917:30UKREGHutchmed (China) Limited Blocklisting Six Monthly Return
2023/6/2617:30UKREGHutchmed (China) Limited HUTCHMED to Announce 2023 Half-Year..
2023/6/1615:00UKREGHutchmed (China) Limited Phase III FRESCO-2 Results in The..
2023/6/1523:39UKREGHutchmed (China) Limited MAA of Fruquintinib Validated by..
2023/6/0918:30RNSNONHutchmed (China) Limited HUTCHMED Highlights Presentations..
2023/6/0618:00UKREGHutchmed (China) Limited LTIP and Share Option Scheme
2023/5/3117:30UKREGHutchmed (China) Limited Total Voting Rights
2023/5/2615:00RNSNONHutchmed (China) Limited HUTCHMED Highlights Presentations..
2023/5/2615:00UKREGHutchmed (China) Limited Fruquintinib NDA Granted Priority..
2023/5/1717:30UKREGHutchmed (China) Limited Standard form for notification of..
2023/5/1221:15UKREGHutchmed (China) Limited Annual General Meeting Poll Results
2023/5/1217:30UKREGHutchmed (China) Limited Board of Directors and Board..
2023/5/1017:30UKREGHutchmed (China) Limited Appointment of Independent NED

最近閲覧した銘柄

Delayed Upgrade Clock